← Leaderboards
Kedarnath Javaly
New York University School Of Medicine
$21,006
Attributed
$21,006
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$21,006 · 1
By mechanism
M01$21,006 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Fred Valentine$14,208,248
- Howard S Hochster$9,390,994
- William Borkowsky$9,487,417
- Franco M Muggia$5,360,861
- William N Rom$26,662,104
Others in their field
Top investigators on “Aids Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$356,191,804
- Constance Ann Benson · University Of California, San Diego$277,003,036
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,875,323
- Barbara Driver · Westat, Inc.$205,980,213
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Carol Nesel · Westat$188,148,170
Research focus
Aids TherapyAntiaids AgentCachexiaClinical ResearchClinical TrialsCombination ChemotherapyHiv InfectionsHuman SubjectHuman Therapy EvaluationRecombinant ProteinsSomatotropin
Grant awards (4)
RECOMBINANT HUMAN GROWTH HORMONE FOR HIV-ASSOCIATED CATABOLISM/WASTING$0
M01 · FY2002 · RR
RECOMBINANT HUMAN GROWTH HORMONE FOR HIV-ASSOCIATED CATABOLISM/WASTING$0
M01 · FY2001 · RR
RECOMBINANT HUMAN GROWTH HORMONE FOR HIV-ASSOCIATED CATABOLISM/WASTING$21,006
M01 · FY2000 · RR
RECOMBINANT HUMAN GROWTH HORMONE FOR HIV-ASSOCIATED CATABOLISM/WASTING$0
M01 · FY2000 · RR